Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 1/2012

01.01.2012 | 2011 SSAT Plenary Presentation

Is It Worth Looking? Abdominal Imaging After Pancreatic Cancer Resection: a National Study

verfasst von: Elan R. Witkowski, Jillian K. Smith, Elizaveta Ragulin-Coyne, Sing-Chau Ng, Shimul A. Shah, Jennifer F. Tseng

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Abdominal imaging is often performed after pancreatic cancer resection. We attempted to quantify the volume and estimate the cost of complex imaging after pancreatectomy nationwide, and to determine whether their frequent use confers benefit.

Methods

Patients with pancreatic adenocarcinoma who underwent resection were identified in Surveillance, Epidemiology and End Results–Medicare (1991–2005). Claims for abdominal imaging ≤5 years after resection were analyzed. Patients receiving annual CT scans were identified. Univariate and multivariate analyses were performed. To assess frequency of annual CT scanning in patients with superior survival, the top decile was further analyzed.

Results

Eleven thousand eight hundred fifty studies were performed on 2,217 patients. Ten thousand five hundred forty-two (89%) were CT scans. The median number of scans doubled from three in 1991 to six in 2005 (p < 0.0001). Among patients with sufficient survival to allow for analysis, 51.3% received annual CT scans, while only 32.4% of top-performing patients received annual scans. Univariate analysis of the 10% of patients with superior survival did not reveal any significant benefit associated with annual imaging.

Conclusion

Utilization of complex imaging after pancreatic cancer resection has increased substantially among Medicare beneficiaries, driven primarily by an increasing number of CT scans. Our study demonstrated no significant survival benefit among patients who received scans on a routine basis.
Literatur
1.
Zurück zum Zitat Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control. May 2006;17(4):403–409.PubMedCrossRef Cress RD, Yin D, Clarke L, Bold R, Holly EA. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control. May 2006;17(4):403–409.PubMedCrossRef
2.
Zurück zum Zitat Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. Aug 2007;246(2):173–180.PubMedCrossRef Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. Aug 2007;246(2):173–180.PubMedCrossRef
3.
Zurück zum Zitat Carroll JE, Smith JK, Simons JP, et al. (2010) Redefining mortality after pancreatic cancer resection. J Gastrointest Surg 14(11):1701–1708.PubMedCrossRef Carroll JE, Smith JK, Simons JP, et al. (2010) Redefining mortality after pancreatic cancer resection. J Gastrointest Surg 14(11):1701–1708.PubMedCrossRef
4.
Zurück zum Zitat Riall TS, Nealon WH, Goodwin JS, et al. Pancreatic cancer in the general population: Improvements in survival over the last decade. J Gastrointest Surg. Nov 2006;10(9):1212–1223; discussion 1223–1214.PubMedCrossRef Riall TS, Nealon WH, Goodwin JS, et al. Pancreatic cancer in the general population: Improvements in survival over the last decade. J Gastrointest Surg. Nov 2006;10(9):1212–1223; discussion 1223–1214.PubMedCrossRef
5.
Zurück zum Zitat Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. Mar 2008;247(3):456–462.PubMedCrossRef Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg. Mar 2008;247(3):456–462.PubMedCrossRef
6.
Zurück zum Zitat Simons JP, Shah SA, Ng SC, Whalen GF, Tseng JF. National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg. Oct 2009;13(10):1798–1805.PubMedCrossRef Simons JP, Shah SA, Ng SC, Whalen GF, Tseng JF. National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg. Oct 2009;13(10):1798–1805.PubMedCrossRef
7.
Zurück zum Zitat Dinan MA, Curtis LH, Hammill BG, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999–2006. JAMA. Apr 28 2010;303(16):1625–1631.PubMedCrossRef Dinan MA, Curtis LH, Hammill BG, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999–2006. JAMA. Apr 28 2010;303(16):1625–1631.PubMedCrossRef
9.
Zurück zum Zitat Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. Aug 2002;40(8 Suppl):IV-55-61. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. Aug 2002;40(8 Suppl):IV-55-61.
10.
Zurück zum Zitat Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res. 2008;8:12.PubMedCrossRef Li B, Evans D, Faris P, Dean S, Quan H. Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res. 2008;8:12.PubMedCrossRef
11.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. Jun 1992;45(6):613–619.PubMedCrossRef Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. Jun 1992;45(6):613–619.PubMedCrossRef
12.
Zurück zum Zitat Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. Dec 2000;53(12):1258–1267.PubMedCrossRef Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. Dec 2000;53(12):1258–1267.PubMedCrossRef
14.
Zurück zum Zitat Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. Journal of the American Statistical Association. June 1958;53(282):457–481.CrossRef Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. Journal of the American Statistical Association. June 1958;53(282):457–481.CrossRef
15.
Zurück zum Zitat Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical care. Aug 2002;40(8 Suppl):IV-104-117. Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Medical care. Aug 2002;40(8 Suppl):IV-104-117.
16.
Zurück zum Zitat Simons JP, Ng SC, McDade TP, Zhou Z, Earle CC, Tseng JF. Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices. Cancer. Apr 1 2010;116(7):1681–1690.PubMedCrossRef Simons JP, Ng SC, McDade TP, Zhou Z, Earle CC, Tseng JF. Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices. Cancer. Apr 1 2010;116(7):1681–1690.PubMedCrossRef
Metadaten
Titel
Is It Worth Looking? Abdominal Imaging After Pancreatic Cancer Resection: a National Study
verfasst von
Elan R. Witkowski
Jillian K. Smith
Elizaveta Ragulin-Coyne
Sing-Chau Ng
Shimul A. Shah
Jennifer F. Tseng
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 1/2012
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1699-z

Weitere Artikel der Ausgabe 1/2012

Journal of Gastrointestinal Surgery 1/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.